Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid in COVID-19 Outpatients
NCT04338074Phase 2Terminated
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Tranexamic Acid Treatment with Placebo Treatment (2 arms). Primary endpoint: Need for Hospitalization at 7 days. Started Jun 2020; status: terminated.
02
Drugs
tranexamic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04338074.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04338074.